Drug discovery

#Cardiovascular disease #Collaboration #Drug discovery #Flagship Pioneering #Partnership #Pfizer

Flagship and Quotient partner on cardiovascular disease therapies

Pfizer has expanded its strategic partnership with Flagship Pioneering, adding two new research programmes with Flagship-founded Quotient Therapeutics. Under the collaboration, the companies will analyse somatic mutations that occur in diseased patient tissue to inform the discovery and development of therapies for cardiovascular and renal diseases. Read More

#Business & Investment #News

GBP pound sterling funding
#Drug discovery #Funding #Innovate UK

UK drug discovery companies receive share of £17.8M fund

Therapeutics companies developing immunotherapies, mRNA vaccines and anti-inflammatory therapies have been chosen to receive funding from Innovate UK Biomedical Catalyst. In total, thirty projects will receive a share of £17.8 ($23.5) million from Biomedical Catalyst, Innovate UK’s flagship grant funding mechanism. Biomedical Catalyst was… Read More

#Business & Investment #News

#Automation / robotics #Drug discovery

Webinar: Customizing Biosafety Cabinets: A Holistic Approach

Watch this on-demand webinar to learn more about: Situations that may require a bespoke biosafety cabinet The process to collaborate with a manufacturer to build a bespoke Planning for the certification and service requirements of a bespoke design   Brought to you… Read More

#Webinars

#AAV #Cryo-EM #cryo-microscopy #Drug discovery #Gene therapy #Webinar

Register now: AAV characterisation using cryo-EM and deep learning

In a webinar on 5 September, Professor Susumu Uchiyama, Department of Biotechnology, Graduate School of Engineering, Osaka University, will present his work around adeno-associated virus (AAV) characterisation using cryo-electron microscopy. The event is hosted by DDW and supported by Thermo Fisher Scientific. In… Read More

Webinar date:
Supported by Thermo Fisher Scientific
#News

Antibodies
#Antibodies #Antibody #Antibody discovery workflow #Drug discovery #Webinar

Learn how to produce high-affinity & specificity rabbit mAbs

Traditional hybridoma technology has long struggled with inefficiencies, especially in producing rabbit monoclonal antibodies. Join DDW on 9 September 3PM BST to find out how Fujifilm Wako has surmounted these challenges by integrating DNA immunisation with their proprietary single B-cell cloning technique, paving the way for… Read More

Webinar date:
Supported by Oxford Nanopore Technologies
#News

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Automated workflows #Automation #Automation / robotics #Biopharma #Biopharmaceuticals #Data science #Drug development #Drug discovery #Lab automation #Lab technology #Personalised medicine #Pharmaceuticals

New podcast: How technology is impacting drug discovery

This is the latest episode of the free DDW narrated podcast, titled “How technology is impacting drug discovery”, which covers two articles written for Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: AI is critical to solving new complexities in drug discovery and… Read More

#News

#Drug discovery

eBook: Unlock Human-Relevant Insights with Organ-on-a-Chip Technology

Organ-Chips have seen significant growth in adoption over the past few years. A blinded survey across industry and academia found: 97% of experienced Organ-Chip users say the technology is more predictive than conventional in vitro models. 70% of experienced Organ-Chip users describe the technology as more predictive than… Read More

#eBooks

#Drug discovery

Guide: Lipid Nanoparticle Formulation: Basic Concepts & Preparation Procedures

Lipid nanoparticles (LNPs) have great potential to revolutionize the development of nucleic acid therapies. Download the guide to learn more about: The basic concepts and components of lipid-based drug delivery systems Important considerations for LNP design, stability, and storage Techniques for LNP preparation, characterization, and functional assessment… Read More

#Guides

Brain inflammation
#Cell culture #Drug discovery #High throughput screening #In vitro #Neuroscience

Balancing in vitro models of neuroinflammation

Dr Gareth Edwards, Senior Bioassay Scientist at Cellomatics Biosciences, explores how modern techniques and high-throughput screening can enhance workflows in neuroinflammation.  Inflammation occurs when specific stimuli induce phenotypic changes by activating signalling cascades that amplify downstream responses. It plays vital roles in both disease progression and tissue repair; in other… Read More

#Exclusive Content

#AAV #Cryo-EM #cryo-microscopy #Drug discovery #Gene therapy #Webinar

Webinar: Discover AAV characterisation using cryo-EM

In a webinar on 5 September, Professor Susumu Uchiyama, Department of Biotechnology, Graduate School of Engineering, Osaka University, will present his work around adeno-associated virus (AAV) characterisation using cryo-electron microscopy. The event is hosted by DDW and supported by Thermo Fisher Scientific. In… Read More

Webinar date:
Supported by Thermo Fisher Scientific
#News

Antibodies
#Antibodies #Antibody #Antibody discovery workflow #Drug discovery #Webinar

Next-gen antibody discovery: Leveraging DNA immunisation

Traditional hybridoma technology has long struggled with inefficiencies, especially in producing rabbit monoclonal antibodies. Join DDW on 9 September 3PM BST to find out how Fujifilm Wako has surmounted these challenges by integrating DNA immunisation with their proprietary single B-cell cloning technique, paving the way for… Read More

Webinar date:
Supported by Oxford Nanopore Technologies
#News

#Bioactive proteins #Drug development #Drug discovery #Plant-based #Synthetic biology #Tokyo University of Science

New way to synthesise bioactive compounds for drug discovery

Researchers at Tokyo University of Science have successfully developed a new method to synthesise eutyscoparol A and violaceoid C, two naturally occurring compounds with promising antimalarial and antibacterial properties. The new approach involves the synthesis of these compounds using readily available dinitriles. This method requires fewer… Read More

#News

#AAV #Cryo-EM #cryo-microscopy #Drug discovery #Gene therapy #Webinar

Webinar: Adeno-associated virus vectors for gene therapy

In a webinar on 5 September, Professor Susumu Uchiyama, Department of Biotechnology, Graduate School of Engineering, Osaka University, will present his work around adeno-associated virus (AAV) characterisation using cryo-electron microscopy. The event is hosted by DDW and supported by Thermo Fisher Scientific. In… Read More

Webinar date:
Supported by Thermo Fisher Scientific
#News

#AAV #Cryo-EM #cryo-microscopy #Drug discovery #Gene therapy

Quantitative analysis of full and empty particles in adeno-associated virus vectors for gene therapy

In this event, Professor Susumu Uchiyama, Department of Biotechnology, Graduate School of Engineering, Osaka University, presents his work around adeno-associated virus (AAV) characterisation using cryo-electron microscopy. In recent years, AAV vectors have been launched and are considered one of the main platforms for gene therapy, with more than 250 clinical… Read More

Webinar date:
Supported by Thermo Fisher Scientific
#Webinars

Antibodies
#Antibodies #Antibody #Antibody discovery workflow #Drug discovery #Webinar

New webinar: Next-generation antibody discovery

Traditional hybridoma technology has long struggled with inefficiencies, especially in producing rabbit monoclonal antibodies. Join DDW on 9 September 3PM BST to find out how Fujifilm Wako has surmounted these challenges by integrating DNA immunisation with their proprietary single B-cell cloning technique, paving the way for… Read More

Webinar date:
Supported by Oxford Nanopore Technologies
#News

Antibodies
#Antibodies #Antibody #Antibody discovery workflow #Drug discovery

Next-gen antibody discovery: Leveraging DNA immunisation and single B-cell cloning for high-affinity & specificity rabbit mAbs

Watch this engaging and informative webinar on Fujifilm Wako’s groundbreaking advancements in rabbit monoclonal antibody discovery. Traditional hybridoma technology has long struggled with inefficiencies, especially in producing rabbit monoclonal antibodies. Fujifilm Wako has surmounted these challenges by integrating DNA immunisation with its proprietary single B-cell cloning technique, paving the way… Read More

Webinar date:
Supported by Fujifilm Wako
#Webinars